Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Approved / Repurposing

There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.

Approved Drug Library
L1000
A unique collection of 2818 approved drugs for high throughput screening (HTS) and high content screening (HCS);
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
FDA-Approved & Pharmacopeia Drug Library
L1010
3215 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
FDA-Approved Drug Library
L4200
A unique collection of 1810 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Clinical Compound Library
L3400
A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Preclinical Compound Library
L3410
A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);
  • Inquiry Price
Size
QTY
Drug Repurposing Compound Library
L9200
A unique collection of 4921 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited